Given the high therapeutic relevance of EGFR-related pathways and the lack of understanding regarding the interplay of miR-218 and EGFR in breast cancer, we aimed to determine the relation between miR-218, EGFR and therapy resistance in breast cancer. This evidence concerns the gene EGFR and breast carcinoma.